Halozyme Therapeutics, Inc.
HALO
$63.65
-$1.48-2.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 142.82M | 701.96M | 548.18M | 747.92M | 596.07M |
| Total Receivables | 441.27M | 346.04M | 316.34M | 304.62M | 308.46M |
| Inventory | 176.48M | 185.80M | 181.51M | 164.87M | 141.86M |
| Prepaid Expenses | 64.64M | 94.96M | 76.65M | 44.62M | 38.95M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 825.21M | 1.33B | 1.12B | 1.26B | 1.09B |
|
|
|||||
| Total Current Assets | 825.21M | 1.33B | 1.12B | 1.26B | 1.09B |
| Net Property, Plant & Equipment | 82.14M | 71.42M | 71.52M | 72.82M | 75.04M |
| Long-term Investments | 580.36M | 416.82M | 416.82M | 416.82M | 416.82M |
| Goodwill | 580.36M | 416.82M | 416.82M | 416.82M | 416.82M |
| Total Other Intangibles | 981.47M | 348.54M | 366.31M | 384.07M | 401.83M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 56.15M | 55.70M | 76.58M | 60.80M | 84.45M |
| Total Assets | 2.53B | 2.22B | 2.05B | 2.20B | 2.06B |
|
|
|||||
| Total Accounts Payable | 20.90M | 15.36M | 18.69M | 20.07M | 10.25M |
| Total Accrued Expenses | 144.92M | 111.18M | 115.59M | 130.31M | 128.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.28M | 710.69M | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 177.09M | 837.23M | 134.28M | 150.38M | 139.10M |
|
|
|||||
| Total Current Liabilities | 177.09M | 837.23M | 134.28M | 150.38M | 139.10M |
| Long-Term Debt | 2.14B | 800.07M | 1.51B | 1.51B | 1.51B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 23.29M | 28.10M | 28.97M | 29.39M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 133.50M | 51.92M | 48.80M | 27.05M | 54.76M |
| Total Liabilities | 2.48B | 1.72B | 1.72B | 1.71B | 1.70B |
|
|
|||||
| Common Stock & APIC | 12.12M | 24.03M | 118.00K | 7.72M | 123.00K |
| Retained Earnings | 54.79M | 502.15M | 361.03M | 477.96M | 359.87M |
| Treasury Stock & Other | -18.09M | -22.26M | -28.40M | -3.41M | 3.83M |
| Total Common Equity | 48.81M | 503.92M | 332.75M | 482.27M | 363.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.81M | 503.92M | 332.75M | 482.27M | 363.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.81M | 503.92M | 332.75M | 482.27M | 363.82M |
|
|
|||||